• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

按人头付费、管理式医疗与慢性阻塞性肺疾病

Capitation, managed care, and chronic obstructive pulmonary disease.

作者信息

Grasso M E, Weller W E, Shaffer T J, Diette G B, Anderson G F

机构信息

School of Medicine, Department of Health Policy and Management, and Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.

出版信息

Am J Respir Crit Care Med. 1998 Jul;158(1):133-8. doi: 10.1164/ajrccm.158.1.9710041.

DOI:10.1164/ajrccm.158.1.9710041
PMID:9655719
Abstract

Expenditure and utilization patterns of aged Medicare beneficiaries with chronic obstructive respiratory disease (COPD) (n = 42,472) were compared with all Medicare beneficiaries (n = 1,221,615) using a 5% nationally representative sample of aged Medicare beneficiaries participating in the fee-for-service program in 1992. Per capita expenditures for an aged Medicare beneficiary with COPD were 2.4 times the per capita expenditures for all Medicare beneficiaries. The most expensive 10% of Medicare beneficiaries with COPD accounted for nearly half of total expenditures for this population. Higher comorbidity, as measured by the Deyo-adapted Charlson index, was associated with higher expenditures. For Medicare Part B claims, internal medicine accounted for the largest portion of physician expenditures (14%). Per capita expenditures for pulmonologists were 7.5 times higher for beneficiaries with COPD compared with all Medicare beneficiaries. Results from this study suggest that there is a subgroup of individuals with COPD who are likely to be very expensive during the year. Additional analytic studies are needed to more specifically identify characteristics associated with these individuals. As more Medicare beneficiaries enroll in managed care and as physicians are increasingly being paid on a capitated basis this information will be useful to physicians as they monitor the care provided to patients and assess the financial risks they accept under capitation.

摘要

使用1992年参与按服务收费计划的5%具有全国代表性的老年医疗保险受益人的样本,将患有慢性阻塞性呼吸道疾病(COPD)的老年医疗保险受益人(n = 42,472)的支出和使用模式与所有医疗保险受益人(n = 1,221,615)进行比较。患有COPD的老年医疗保险受益人的人均支出是所有医疗保险受益人平均支出的2.4倍。患有COPD的医疗保险受益人中花费最高的10%占该人群总支出的近一半。通过Deyo调整后的Charlson指数衡量,较高的合并症与较高的支出相关。对于医疗保险B部分索赔,内科医生支出占医生支出的最大部分(14%)。患有COPD的受益人的肺科医生人均支出比所有医疗保险受益人高出7.5倍。这项研究的结果表明,有一部分COPD患者在这一年中可能花费非常高。需要进行更多的分析研究,以更具体地确定与这些患者相关的特征。随着越来越多的医疗保险受益人加入管理式医疗,以及医生越来越多地按人头付费,这些信息对于医生监测为患者提供的护理以及评估他们在按人头付费情况下所承担的财务风险将是有用的。

相似文献

1
Capitation, managed care, and chronic obstructive pulmonary disease.按人头付费、管理式医疗与慢性阻塞性肺疾病
Am J Respir Crit Care Med. 1998 Jul;158(1):133-8. doi: 10.1164/ajrccm.158.1.9710041.
2
Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns.管理式医疗下的阿尔茨海默病:医疗保险利用情况及支出模式的影响
J Am Geriatr Soc. 1998 Jun;46(6):762-70. doi: 10.1111/j.1532-5415.1998.tb03814.x.
3
How well does a single question about health predict the financial health of Medicare managed care plans?关于健康的单个问题对医疗保险管理式医疗计划的财务健康状况预测效果如何?
Eff Clin Pract. 1999 Mar-Apr;2(2):56-62.
4
Explaining the increased health care expenditures associated with gastroesophageal reflux disease among elderly Medicare beneficiaries with chronic obstructive pulmonary disease: a cost-decomposition analysis.解释老年医疗保险受益人群中患有慢性阻塞性肺病的患者中胃食管反流病相关医疗费用增加的原因:成本分解分析。
Int J Chron Obstruct Pulmon Dis. 2014 Apr 8;9:339-48. doi: 10.2147/COPD.S59139. eCollection 2014.
5
The implementation of managed behavioral healthcare in Colorado and the effects on older Medicaid beneficiaries.科罗拉多州管理式行为医疗保健的实施及其对老年医疗补助受益人的影响。
J Ment Health Policy Econ. 2006 Mar;9(1):15-24.
6
Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer's disease and related disorders.阿尔茨海默病和相关疾病患者的医疗保险潜在可避免住院治疗。
Alzheimers Dement. 2013 Jan;9(1):30-8. doi: 10.1016/j.jalz.2012.11.002.
7
Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.长期护理机构中医疗保险受益人的慢性阻塞性肺疾病负担
Am J Geriatr Pharmacother. 2009 Oct;7(5):262-70. doi: 10.1016/j.amjopharm.2009.11.003.
8
Health care utilization by old-old long-term care facility residents: how do Medicare fee-for-service and capitation rates compare?高龄长期护理机构居民的医疗保健利用情况:医疗保险按服务收费制和人头费率如何比较?
J Am Geriatr Soc. 2000 Oct;48(10):1330-6.
9
Association of managed care market share and health expenditures for fee-for-service Medicare patients.按服务收费的医疗保险患者的管理式医疗市场份额与医疗支出的关联
JAMA. 1999 Feb 3;281(5):432-7. doi: 10.1001/jama.281.5.432.
10
Patterns of expenditures and use of services among older adults with diabetes. Implications for the transition to capitated managed care.糖尿病老年患者的支出模式及服务使用情况。对向按人头付费的管理式医疗转变的启示。
Diabetes Care. 1998 May;21(5):747-52. doi: 10.2337/diacare.21.5.747.

引用本文的文献

1
Healthcare Utilization in Patients with Chronic Obstructive Pulmonary Disease Discharged from Coronavirus 2019 Hospitalization.慢性阻塞性肺疾病患者出院后对冠状病毒 2019 住院的医疗利用。
Int J Chron Obstruct Pulmon Dis. 2023 Aug 22;18:1827-1835. doi: 10.2147/COPD.S415621. eCollection 2023.
2
The Effects of the Health System Response to the COVID-19 Pandemic on Chronic Disease Management: A Narrative Review.卫生系统应对新冠疫情对慢性病管理的影响:一项叙述性综述
Risk Manag Healthc Policy. 2021 Feb 15;14:575-584. doi: 10.2147/RMHP.S293471. eCollection 2021.
3
Direct and indirect economic and health consequences of COPD in Denmark: a national register-based study: 1998-2010.
丹麦慢性阻塞性肺疾病的直接和间接经济及健康后果:一项基于全国登记的研究:1998 - 2010年
BMJ Open. 2014 Jan 6;4(1):e004069. doi: 10.1136/bmjopen-2013-004069.
4
Influenza vaccination in adults with chronic obstructive pulmonary disease: the impact of a diagnostic breathing test on vaccination rates.成人慢性阻塞性肺疾病患者的流感疫苗接种:诊断性呼吸测试对疫苗接种率的影响。
PLoS One. 2013 Jun 28;8(6):e67600. doi: 10.1371/journal.pone.0067600. Print 2013.
5
Clinical factors affecting the direct cost of patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.影响慢性阻塞性肺疾病急性加重住院患者直接费用的临床因素。
Int J Med Sci. 2012;9(4):285-90. doi: 10.7150/ijms.4039. Epub 2012 Jun 5.
6
Discriminative and predictive properties of disease-specific and generic health status indexes in elderly COPD patients.老年慢性阻塞性肺疾病患者中疾病特异性和一般健康状况指标的鉴别及预测特性
BMC Pulm Med. 2008 Aug 13;8:14. doi: 10.1186/1471-2466-8-14.
7
A Markov model to evaluate hospital readmission.一种用于评估医院再入院情况的马尔可夫模型。
BMC Med Res Methodol. 2008 Apr 22;8:23. doi: 10.1186/1471-2288-8-23.
8
Cost-effectiveness of smoking cessation and the implications for COPD.戒烟的成本效益及其对慢性阻塞性肺疾病的影响。
Int J Chron Obstruct Pulmon Dis. 2006;1(3):279-87. doi: 10.2147/copd.2006.1.3.279.
9
Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone.与单独使用每种单一成分相比,布地奈德/福莫特罗单一吸入器治疗慢性阻塞性肺疾病的成本效益。
Pharmacoeconomics. 2005;23(4):365-75. doi: 10.2165/00019053-200523040-00006.
10
Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004.慢性阻塞性肺疾病进展的评估:2004年3月11日至12日在鲁汶举办的研讨会报告
Thorax. 2005 Apr;60(4):335-42. doi: 10.1136/thx.2004.028712.